|
Melting curve-based assay as an alternative technique for the accurate detection of SARS-CoV-2
Shima Aboutalebian1, Somaye Mirzaaghaei1, Hamed Fakhim2, Sama Faramarzi1, Somayeh Mousavi1, Safiyeh Ghafel3, Sahar Gholipour4, Armin Farhang5, Hossein Mirhendi6, Mahnaz Nikaeen7
1 Department of Medical Parasitology and Mycology, School of Medicine, & Research Core Facilities Laboratory, Isfahan University of Medical Sciences, Isfahan, Iran
2 Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3 Department of Medical Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
4 Department of Environmental Health Engineering, Faculty of Health, Kashan University of Medical Sciences, Isfahan, Iran
5 Department of Pharmaceutical Biotechnology, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
6 Department of Medical Parasitology and Mycology, School of Medicine, & Research Core Facilities Laboratory, Isfahan University of Medical Sciences, Isfahan, Iran
7 Department of Environmental Health Engineering, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
| Date of Submission | 19-Apr-2021 |
| Date of Acceptance | 13-Nov-2021 |
| Date of Web Publication | 30-May-2022 |
Correspondence Address:
Prof. Hossein Mirhendi
Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/abr.abr_87_21
Background: Early and cost-effective diagnosis and monitoring of the infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critically important to anticipate and control the disease. We aimed to set up a SYBR Green-based one-step real-time polymerase chain reaction (PCR) as a lower-cost alternative method to detect the virus. Materials and Methods: An in-house SYBR Green-based PCR assay targeting the envelope (E) and RNA-dependent RNA polymerase (RdRp) genes, was set up to diagnose the infection, and was compared with the reference probe-based PCR method. Results: When the commercial probe-based assay was considered as the reference method, SYBR Green-based PCR had a slightly lower sensitivity (81.98% and 86.25% for E and RdRp targets, respectively) and a good specificity (100% and 94.44% for E and RdRp targets, respectively). For both gene targets, three different melting temperature (Tm) patterns were found in the PCRs of the nasopharyngeal/oropharyngeal swab samples, but no size polymorphism was seen in agarose gel electrophoresis. Conclusion: Further studies to improvement of the assay are needed to make it an inexpensive and reliable tool for the diagnosis of COVID-19.
Keywords: E-gene, RdRp-gene, SARS-CoV-2, SYBR Green, Diagnosis Biological Assay
How to cite this article:
Aboutalebian S, Mirzaaghaei S, Fakhim H, Faramarzi S, Mousavi S, Ghafel S, Gholipour S, Farhang A, Mirhendi H, Nikaeen M. Melting curve-based assay as an alternative technique for the accurate detection of SARS-CoV-2. Adv Biomed Res 2022;11:37 |
How to cite this URL:
Aboutalebian S, Mirzaaghaei S, Fakhim H, Faramarzi S, Mousavi S, Ghafel S, Gholipour S, Farhang A, Mirhendi H, Nikaeen M. Melting curve-based assay as an alternative technique for the accurate detection of SARS-CoV-2. Adv Biomed Res [serial online] 2022 [cited 2022 Oct 3];11:37. Available from: https://www.advbiores.net/text.asp?2022/11/1/37/346318 |
| Introduction | |  |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious virus causing a range of mild-to-severe infections.[1] Since the emergence of this disease in late 2019, health care systems have experienced a variety of challenges including diagnosis, treatment, and prevention.[2] Although the majority of the infected people are asymptomatic[3] or represent mild symptoms with no significant patterns of computed tomography (CT) of the chest,[4] this disease has caused a high rate of spread and subsequent increased mortality rate. The virus may affects many organs. It binds to host receptors (angiotensin-converting enzyme 2) and penetrate by endocytosis or membrane fusion, viral contents are released inside the host cells, its RNA enters the nucleus, and viral messenger RNA is used to make viral proteins. Recruitment of inflammatory interleukin 6 secreting monocytes caused severe lung pathology in patients with COVID-19. Release of the virus in the lung cells leads to nonspecific symptoms such as fever, myalgia, headache, and respiratory symptoms.[5]
Reliable and cost-effective diagnosis is urgent to improve the management of the patients and to investigate the inter/intra society outbreaks. Regarding the emergency of proper diagnosis, different molecular detection methods have been conducted mainly based on polymerase chain reaction (PCR), real-time-PCR (rt-PCR),[6] multiplex PCR,[7] loop-mediated isothermal amplification,[8] aptamere,[9] and CRISPR-Cas.[10] Different approaches of rt-PCR are regarded as the methods of choice for the detection of coronavirus disease 2019 (COVID-19) from nasopharyngeal and oropharyngeal samples.[11],[12] TaqMan probe-based reverse transcription real-time PCR assay, based on the detection of a specific complementary sequence of the pathogen in a specifically amplified region, has been accepted as the golden standard for the detection of the viral pathogen in clinical samples. However, in dye-based rt-PCR detection using SYBR Green or Eva Green, the presence of a specific amplified sequence is considered. Dissociation characteristics of double-stranded DNA during heating can be assessed by melting curve analysis, in which with raising the temperature, the DNA strands begin to dissociate that results in rising in the absorbance intensity. The dissociation between two strands of amplified DNA can be measured using SYBR Green, EvaGreen, or fluorophore-labeled DNA probes (https://en.wikipedia.org/wiki/Melting_curve_analysis). Although the probe-based method indicates higher specificity than the SYBR Green-based technique, the latter is less expensive[13] and suitable for the detection of variable genotypes in pathogens.[14]
Following the complete genome sequence analysis of SARS-CoV-2,[15] several diagnostic strategies have been developed targeting specific sequences in the structural spike (S), nucleocapsid (N), membrane (M), envelope (E), or nonstructural protein-coding genes (nsp) required for virus replication (i.e., nsp12 or RNA-dependent RNA polymerase [RdRp], nsp13 or helicase [hel], and open reading frames [ORF] 1ab).[16] Considering the high specificity of the probe-based method on one hand, and the mutation capacity of the RNA virus, its anomalous transmission, and its spread (which positively affects an increased number of derivative subspecies) on the other hand, probe-based detection may encounter false-negative results because of the mutation in probe-target sequences.[17]
In the present study, we aimed to set up a SYBR Green-based one-step reverse transcription real-time PCR method as an alternative for probe-based real-time PCR to detect the COVID-19 virus. This lower-cost approach was compared with the routine TaqMan probe-based rt-PCR approach. The method can be used in conditions that supplying specific and/or expensive probes reagents or kits are difficult.
| Materials and Methods | | |
Clinical samples
This study included a total of 200 clinical specimens consisting of 100 samples from hospitalized patients with a COVID-19 and 100 samples from suspected patients who were in contact with affected individuals or indicated some clinical signs of COVID-19 and referred to healthcare centers affiliated to Isfahan University of Medical Sciences, Isfahan, Iran. The nasopharyngeal/oropharyngeal swab samples were collected in hospitals and health centers and kept at collection tubes containing a virus transport medium. All samples and experiments were processed at COVID-19 diagnostic laboratory, Research Core Facility Lab, Isfahan University of Medical Sciences, Isfahan, Iran.
Probe-based reverse transcription real-time PCR assay
The RNA was extracted and purified using a viral RNA isolation kit (ROJE, Iran) according to the manufacturer's instructions, and stored at −20°C until to use. A 10 μL aliquot of extracted RNAs were subjected to SARS-CoV-2-specific probe-based one-step rt-PCR kit (Sansure Biotech, China), targeting the N gene and ORF-1ab region, according to the manufacturer's protocol. The amplification was performed with a cycle of 30 min at 50°C for reverse transcription and 1 min at 95°C for primary denaturation, followed by 45 cycles of 95°C (15 s) and 60°C (30 s), by the LightCycler® 96 Instrument (Roche Life Science, Germany). According to the manufacturer's protocol, CT <40 in both genes was considered positive.
SYBR Green-based real-time-polymerase chain reaction assay
The SYBR Green-based PCR was conducted on the same extracted RNAs used for probe-based PCR, using the reverse transcription enzyme included in the PCR reagent set of COVID-19 kits (Da An gene, China), and the SolisGreen qPCR Mix (Solis BioDyne, Estonia) in one tube. The specific primers for the target genes E,[18] RdRp,[19] and ORF-1ab[20] of the SARS-CoV-2 were used separately [Table 1]. A total reaction mixture of 15 μL was prepared for each sample containing 5 μL of the RNA template, 0.3 μL (0.2 μM) of each primer, 3 μL of 5X master mix, and 1 μL of reverse transcriptase enzyme. The thermal program was 30 min at 50°C for reverse transcription and 15 min at 95°C to inactivate the enzyme as well as to activate the Taq DNA polymerase, followed by 45 cycles of 95°C for 15 s, and 57°C for 45 s. At the end of the program, melting curve analysis ranging from 60–95°C with acquiring fluorescence data every 0.3°C was performed. All reactions were performed using the LightCycler® 96 Instrument (Roche, Germany). | Table 1: The sequence of each primer and the relevant amplicon sizes, the sensitivity and specificity of each primer pair used in this study
Click here to view |
Agarose gel electrophoresis
To obtain an objective judgment on any possible size polymorphism or additional amplicons, a total of 14 random samples representing each relevant pattern and having different melting temperatures (Tm) in SYBR Green RT-rt-PCR, were subjected to 2% agarose gel electrophoresis. The gels were stained with 0.5 μg/ml ethidium bromide and visualized under ultraviolet light.
Statistical analysis
The sensitivity and specificity of SYBR Green-based RT-rt-PCR in the detection of COVID-19 by two primer sets were determined using Fisher's test using Graphpad Prism 6. A P < 0.05 was considered statistically significant.
| Results | | |
Flow diagram depicting the methods and results is shown in [Figure 1]. The samples were from seven different age groups of the patients consisted of under 19 years of age (n = 14), 20–29 years (n = 31), 30–39 years (n = 51), 40–49 years (n = 32), 50–59 years (n = 24), 60–69 years (n = 23), and over 70 years of age (n = 25). Overall, 24 cases of 25 hospitalized patients were aged >70 years, and 37 of 51 patients referred from healthcare centers were 30–39 years. The majority (58.5%, n = 117) of the study population was men. | Figure 1: Flow diagram depicting methods and results of the present study
Click here to view |
Based on the probe-based RT-rt-PCR method, 182 positive and 18 negative samples were selected to be re-tested with the SYBR Green-based PCR assay. [Table 1] indicates the sequence of each primer and the relevant amplicon sizes, the sensitivity and specificity of the tests performed by each primer pair, and the number of each pattern obtained from melting cure analysis. Among 18 samples that were negative in the probe-based PCR test, only one sample become positive using the RdRp primers in the SYBR Green assay. Considering the probe-based assay as a reference method, the sensitivity of the SYBR Green assay was 81.98% and 86.25% when the targets E and RdRp were used, respectively. The assessment of SYBR Green test by ORF-1ab was discontinued following preliminary low sensitivity results. The mean CT values for ORF-1ab and N genes in the commercial probe-based assay were 26.37 and 23.24, respectively, whereas in the SYBR Green-based method, the corresponding values were 26.12 and 24.79 for E and RdRp genes, respectively. After performing the tests for ORF-1ab, the results were negative for the samples with CTs higher than 28 in the probe-based reference assay.
The melting temperature analysis of the SYBR Green PCR assessing E and RdRp genes revealed three defined Tm patterns in both genes. Using the E gene, rt-PCR of the positive samples showed three distinct Tm patterns, i.e., 77.5–78.8, 78.81–79.8, and 79.81–80.8, while using the RdRp gene, the Tm patterns were 78.5–79.5, 79.51–80.5, and 80.51–81.5 [Figure 2]a and [Figure 2]b. To confirm the stability of the Tm patterns, the tests were repeated for 24 samples having different patterns of both E and RdRp genes including 22 positive and two negative samples, and the same results were observed. In spite of existing different Tm patterns in melting curve analysis, no fragments with a size different with 113 bp and 156 bp (for E and RdRp genes, respectively) were observed in agarose gel electrophoresis [Figure 2]c and [Figure 2]d. | Figure 2: Variable melting curve patterns generated in melting curves of SYBR green real time-PCR for the detection of SARS-CoV-2 and the electrophoresis of the PCR products: (a) E gene, (b) RdRp gene, (c) amplified fragment of different melting temperature patterns of E gene, and (d) amplified fragment of different melting temperature patterns in the RdRp gene. M: Molecular size marker.
Click here to view |
| Discussion | | |
Novel β-coronavirus (SARS-CoV-2 infection) has emerged as the most challenging worldwide catastrophe. It is highly contagious with a wide range of severity causing death mostly in susceptible individuals, which rapidly develop among communities worldwide.[21],[22],[23] Rapid and reliable diagnostic tools are critical for detecting the infected people and for isolation and treatment of the patients.[24] In parallel with the clinical signs and symptoms, as well as paraclinical tests such as chest CT, a variety of commercially available probe-based rt-PCRs have been designed and are widely used to provide reliable detection of SARS-CoV-2. The increasing number of samples and subsequent unaffordable costs needed for molecular tests, necessitate introducing alternate, and cost-benefit approaches to diagnostic strategies. To meet this purpose, attempts have been led to assess the efficiency of SYBR Green detection for SARS-CoV-2.[25],[26],[27] Due to the lower cost and processing speed, this methodology can be utilized on a larger scale, providing peace of mind for those being tested and their peers, also guidance for social isolation protocols.[28] Moreover, the high rate of contamination in the ingredients of commercially available kits imposes more costs on the diagnosis process, which reward insisting on in-house less expensive workflows. As SARS-CoV-2 is presented mostly in the upper and lower respiratory systems, nasopharyngeal and oropharyngeal swabs are the best sample types for clinical diagnosis of the virus.[29],[30]
In this study, in-house SYBR Green rt-PCR was compared with commercial probe-based rt-PCR to diagnose SARS-CoV-2 in 200 randomly chosen samples. Compared to commercial probe-based PCR, our in-house method indicated a 100% and 94.44% specificity for E and RdRp genes, respectively; however, the RdRp gene revealed a higher sensitivity compared to E gene (86.25 vs. 81.98%). This indicates acceptable reliability of the SYBR Green rt-PCR approach, in comparison with the probe-based techniques, and proclaims the value of conducting more studies to approve the usage in clinical diagnosis. Nevertheless, its relatively lower sensitivity might be partly due to the fact that after testing the samples with the routine probe-based method, the extracted RNAs were conserved at the freezer and the SYBR Green tests were performed after several months. Melting curve analysis of the rt-PCR has been introduced as a primary approach in molecular diagnosing of different species, serotypes, or genotypes in many organisms. Through the utilization of this approach and a unique set of primers, a variety of melting curve shapes or melting temperatures are capable of discriminating between different amplicons.[14],[31]
The high mutation capacity of the coronaviruses[32] is one of the challenging features of the current pandemic. This would lead to variations in virus characteristics, virulence, pathogenesis, and subsequent challenges in predicting therapeutic and vaccine preparation strategies as previously reported on coronaviruses.[33],[34] The extraordinary virulence capacity of SARS-CoV-2 and the ensuing immense number of infected individuals, extremely increase this mutation chance and enriches the genetic pool of the virus. Although further investigations are needed to clarify the probable association between different variants and the severity of the disease, different melting temperature patterns investigated in this study can be indicative of variable GC content,[26] or the mutations carried by the virus in the population. However, further studies and sequencing analyses are required before making the judgment.
| Conclusion | | |
As the conclusion, an in-house SYBR Green one-step rt-PCR assay using two E and RdRp genes, was compared with a commercial probe-based method to evaluate the probable replacement of the workflow in detecting SARS-CoV-2 in the clinical diagnosing process. The resultant findings indicated an acceptable correspondence with the commercial probe-based rt-PCR, and it looks that it could provide melting temperature differences and consequent evidence regarding probable viral variants in the population and the possible association with the infection contingency and severity.
Acknowledgments
This study was financially supported by Isfahan University of Medical Sciences, Isfahan, Iran, (grant no. 198235), which we gratefully acknowledge.
Ethical conduct of research
Ethical approval of the study was obtained from the ethics committee of Isfahan University of Medical Sciences, Isfahan, Iran (IR. MUI. RESEARCH. REC.1398.778).
Conflicts of interest
There are no conflicts of interest.
| References | | |
| 1. | Wu C, Zheng S, Chen Y, Zheng M. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV, BioRxiv. 2020 Jan 1  |
| 2. | Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536. |
| 3. | Fakhim H, Nasri E, Aboutalebian S, Gholipour S, Nikaeen M, Vaezi A, et al. Asymptomatic carriers of coronavirus disease 2019 among healthcare workers in Isfahan, Iran. Future Virol 2021;16:93-8. |
| 4. | Ren X, Liu Y, Chen H, Liu W, Guo Z, Zhang Y, et al. Application and optimization of RT-PCR in diagnosis of SARS-CoV-2 infection. SSRN Electron J 2020 Feb 25. |
| 5. | Parasher A. COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J 2021;97:312-20. |
| 6. | Toptan T, Hoehl S, Westhaus S, Bojkova D, Berger A, Rotter B, et al. Optimized qRT-PCR approach for the detection of intra-and extra-cellular SARS-CoV-2 RNAs. Int J Mol Sci 2020;21:4396. |
| 7. | Dharavath B, Yadav N, Desai S, Sunder R, Mishra R, Ketkar M, et al. A one-step, one-tube real-time RT-PCR based assay with an automated analysis for detection of SARS-CoV-2. Heliyon 2020;6:e04405. |
| 8. | Jiang M, Pan W, Arastehfar A, Fang W, Fang H, Daneshnia FF, et al. Development and validation of a rapid single-step reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) system potentially to be used for reliable and high-throughput screening of COVID-19. medRxiv 2020; Jun 16;10:331. |
| 9. | Chen Z, Wu Q, Chen J, Ni X, Dai J. A DNA aptamer based method for detection of SARS-CoV-2 nucleocapsid protein. Virol Sin 2020;35:351-4. |
| 10. | |
| 11. | Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol 2020;92:418-23. |
| 12. | Shen M, Zhou Y, Ye J, Abdullah Al-Maskri AA, Kang Y, Zeng S, et al. Recent advances and perspectives of nucleic acid detection for coronavirus. J Pharm Anal 2020;10:97-101. |
| 13. | Pereira-Gómez M, Fajardo Á, Echeverría N, López-Tort F, Perbolianachis P, Costábile A, et al. Evaluation of SYBR green real time PCR for detecting SARS-CoV-2 from clinical samples. J Virol Methods 2021;289:114035. |
| 14. | Eschbaumer M, Li WM, Wernike K, Marshall F, Czub M. Probe-free real-time reverse transcription polymerase chain reaction assays for the detection and typing of porcine reproductive and respiratory syndrome virus in Canada. Can J Vet Res 2015;79:170-9. |
| 15. | Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020;395:565-74. |
| 16. | Tang YW, Schmitz JE, Persing DH, Stratton CW. Laboratory diagnosis of COVID-19: Current issues and challenges. J Clin Microbiol 2020;58:e00512-20. |
| 17. | Tahamtan A, Ardebili A. Real-time RT-PCR in COVID-19 detection: Issues affecting the results. Expert Rev Mol Diagn 2020;20:453-4. |
| 18. | Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020;25:2000045. |
| 19. | Gholipour S, Nikaeen M, Mohammadi Manesh R, Aboutalebian S, Shamsizadeh Z, Nasri E, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contamination of high-touch surfaces in field settings. Biomed Environ Sci 2020;33:925-9. |
| 20. | Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: An observational cohort study. Lancet Infect Dis 2020;20:689-96. |
| 21. | Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – An update on the status. Mil Med Res 2020;7:11. |
| 22. | Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020;55:105924. |
| 23. | Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270-3. |
| 24. | Zhen W, Manji R, Smith E, Berry GJ. Comparison of four molecular in vitro diagnostic assays for the detection of SARS-CoV-2 in nasopharyngeal specimens. J Clin Microbiol 2020;58:e00743-20. |
| 25. | Dorlass EG, Monteiro CO, Viana AO, Soares CP, Machado RR, Thomazelli LM, et al. Lower cost alternatives for molecular diagnosis of COVID-19: Conventional RT-PCR and SYBR green-based RT-qPCR. Braz J Microbiol 2020;51:1117-23. |
| 26. | Fajardo A, Pereira-Gomez M, Echeverria N, Lopez-Tort F, Perbolianachis P, Aldunate F, et al. Evaluation of SYBR green real time PCR for detecting SARS-CoV-2 from clinical samples. bioRxiv 2020; Jan 1. |
| 27. | Sarkar SL, Alam AR, Das PK, Pramanik MH, Al-Emran HM, Jahid IK, et al. Development and validation of cost-effective one-step multiplex RT-PCR assay for detecting the SARS-CoV-2 infection using SYBR green melting curve analysis. medRxiv 2021; Jan 1. |
| 28. | Marinowic DR, Zanirati G, Rodrigues FV, Grahl MV, Alcará AM, Machado DC, et al. A new SYBR green real-time PCR to detect SARS-CoV-2. Sci Rep 2021;11:2224. |
| 29. | Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020;382:1177-9. |
| 30. | Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 2020;323:1843-4. |
| 31. | Wan Z, Zhang Y, He Z, Liu J, Lan K, Hu Y, et al. A melting curve-based multiplex RT-qPCR assay for simultaneous detection of four human coronaviruses. Int J Mol Sci 2016;17:1880. |
| 32. | Woo PC, Lau SK, Huang Y, Yuen KY. Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med (Maywood) 2009;234:1117-27. |
| 33. | Wang ZG, Li LJ, Luo Y, Zhang JY, Wang MY, Cheng SY, et al. Molecular biological analysis of genotyping and phylogeny of severe acute respiratory syndrome associated coronavirus. Chin Med J (Engl) 2004;117:42-8. |
| 34. | Shang L, Qi Y, Bao QY, Tian W, Xu JC, Feng MG, et al. Polymorphism of SARS-CoV genomes. Yi Chuan Xue Bao 2006;33:354-64. |
[Figure 1], [Figure 2]
[Table 1]
|
Search Pubmed for